Manufacturer of Human Induced Pluripotent Stem Cells Achieves Milestone GMP Certification to Manufacture Cord Blood-derived iPSCs
GMP certification and Manufacturing Authorization pave the way for the company to deliver fully characterized clinical-grade iPSCs that are derived from human cord blood cells for the development of cell-based therapies.